Endpoints News 24 nov 2025 Nobel laureate Carolyn Bertozzi to rejoin Lilly board #Carolyn Bertozzi #Eli Lilly
Endpoints News 22 nov 2025 Makary’s user fee comments; M&A activity stays hot; A new use for prime editing; and more #Endpoints Weekly #fee comments
Endpoints News 21 nov 2025 Top Makary aide Jain-Nagpal remains at the FDA after White House pushback #White House #Commissioner Marty
Endpoints News 21 nov 2025 AstraZeneca to onshore rare disease portfolio as part of its $50B pledge to the US #announced Friday #billion pledge
Endpoints News 21 nov 2025 Teva loses IRA drug pricing challenge in DC federal court #federal court #loses IRA
Endpoints News 21 nov 2025 Sarepta ends Elevidys trial with Hansa's pre-treatment; Some pipeline cuts at Moderna #Blue Lake #Inhibikase Therapeutics
Endpoints News 21 nov 2025 FDA investigates child death potentially related to Takeda's enzyme replacement therapy #FDA investigates #blood disorder
Endpoints News 21 nov 2025 Novo, Lilly begin to sell obesity medications directly to employers #Novo Nordisk #Eli Lilly
Endpoints News 21 nov 2025 Contineum's J&J-partnered drug fails Phase 2 multiple sclerosis trial #Thursday afternoon #fails Phase
Endpoints News 21 nov 2025 GSK, AnaptysBio enter legal battle over decade-old Jemperli licensing deal #decade-old Jemperli #drug Jemperli
Endpoints News 21 nov 2025 Jeff Bluestone, Stephen Dilly talk CEO handoff, what’s next for Sonoma; Scott Gottlieb's next move #Stephen Dilly #Scott Gottlieb
Endpoints News 20 nov 2025 Under RFK Jr., vaccine use slides while suspicion rises #vaccine revenue #suspicion rises